These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 17354623)

  • 21. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
    Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
    Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma.
    Soini Y; Kinnula V; Kaarteenaho-Wiik R; Kurttila E; Linnainmaa K; Pääkkö P
    Clin Cancer Res; 1999 Nov; 5(11):3508-15. PubMed ID: 10589765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
    Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
    Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
    Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL-2, TP53 and BAX protein expression in superficial urothelial bladder carcinoma.
    Gonzalez-Campora R; Davalos-Casanova G; Beato-Moreno A; Garcia-Escudero A; Pareja Megia MJ; Montironi R; Lopez-Beltran A
    Cancer Lett; 2007 Jun; 250(2):292-9. PubMed ID: 17126995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma.
    Hsia JY; Chen CY; Hsu CP; Shai SE; Yang SS; Chuang CY; Wang PY; Chen JT
    Neoplasma; 2001; 48(6):483-8. PubMed ID: 11949842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma.
    Sun B; Sun Y; Wang J; Zhao X; Wang X; Hao X
    Eur J Cancer Prev; 2006 Jun; 15(3):258-65. PubMed ID: 16679870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer.
    Paradiso A; Simone G; Lena MD; Leone B; Vallejo C; Lacava J; Dellapasqua S; Daidone MG; Costa A
    Br J Cancer; 2001 Mar; 84(5):651-8. PubMed ID: 11237386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptotic proteins as prognostic markers and indicators of radiochemosensitivity in stage II/III rectal cancers.
    Fucini C; Messerini L; Saieva C; Orzalesi L; Carroni V; Bartolini N
    Colorectal Dis; 2012 Feb; 14(2):e64-71. PubMed ID: 21848899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.
    Sinicrope FA; Evans DB; Leach SD; Cleary KR; Fenoglio CJ; Lee JJ; Abbruzzese JL
    Clin Cancer Res; 1996 Dec; 2(12):2015-22. PubMed ID: 9816161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
    Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
    Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y; Zhang XR; Fu J; Tan W; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
    Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
    Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
    Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
    Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of retinoblastoma and p53 pathway-related proteins in resectable invasive ductal carcinoma of the pancreas: potential cooperative effects on clinical outcome.
    Hashimoto K; Nio Y; Koike M; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2005; 25(2B):1361-8. PubMed ID: 15865092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis in prostate cancer: bax correlation with stage.
    Amirghofran Z; Monabati A; Gholijani N
    Int J Urol; 2005 Apr; 12(4):340-5. PubMed ID: 15948719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.